日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

METTL7A inhibits progression of colorectal cancer through the SREBP1 / FDFT1 / SQLE / CYP51A1 / cholesterol metabolic pathway

METTL7A通过SREBP1/FDFT1/SQLE/CYP51A1/胆固醇代谢途径抑制结直肠癌的进展

Li, Sha; Chi, Xiangyin; Li, Xiaoxue; Li, Wan; Yang, Hong; Cao, Wanxin; Zhao, Yuxuan; Zhang, Xu; Meng, Rui; Du, Guanhua; Zhang, Dan; Wang, Jinhua

Inhibition of UBE2C Promotes Parkin-Mediated K63-Linked Ubiquitination of TOP2A to Induce Senescence and Increase Sensitivity of Doxorubicin in Breast Cancer.

抑制 UBE2C 可促进 Parkin 介导的 TOP2A K63 连接的泛素化,从而诱导衰老并提高乳腺癌对阿霉素的敏感性

Yang Yihui, Li Wan, Yang Hong, Xu Fang, Zhang Sen, Cao Wanxin, Li Xiaoxue, Zhang Xu, Chi Xiangyin, Wang Hongquan, Du Guanhua, Wang Yumin, Wang Jinhua

Synergistic Activity and Mechanism of Sanguinarine with Polymyxin B against Gram-Negative Bacterial Infections

血根碱与多粘菌素B对革兰氏阴性菌感染的协同作用及其机制

Qiao, Luyao; Zhang, Yu; Chen, Ying; Chi, Xiangyin; Ding, Jinwen; Zhang, Hongjuan; Han, Yanxing; Zhang, Bo; Jiang, Jiandong; Lin, Yuan

Erratum to "Identification of anti-Mycobacterium tuberculosis agents targeting the interaction of bacterial division proteins FtsZ and SepFe" [Acta Pharmaceutica Sinica B 13 (2023) 2056-2070]

对“针对细菌分裂蛋白FtsZ和SepFe相互作用的抗结核分枝杆菌药物的鉴定”[中国药学学报B辑 13 (2023) 2056-2070]的勘误

Zhang, Hongjuan; Chen, Ying; Zhang, Yu; Qiao, Luyao; Chi, Xiangyin; Han, Yanxing; Lin, Yuan; Si, Shuyi; Jiang, Jiandong